220 related articles for article (PubMed ID: 7673963)
1. Pretarsal application of botulinum toxin for treatment of blepharospasm.
Aramideh M; Ongerboer de Visser BW; Brans JW; Koelman JH; Speelman JD
J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):309-11. PubMed ID: 7673963
[TBL] [Abstract][Full Text] [Related]
2. Pretarsal blepharospasm: Clinical and electromyographic characteristics.
Grandas F; Traba A; Perez-Sanchez JR; Esteban A
Clin Neurophysiol; 2020 Jul; 131(7):1678-1685. PubMed ID: 32280019
[TBL] [Abstract][Full Text] [Related]
3. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm.
Aramideh M; Ongerboer de Visser BW; Devriese PP; Bour LJ; Speelman JD
Brain; 1994 Feb; 117 ( Pt 1)():27-38. PubMed ID: 8149212
[TBL] [Abstract][Full Text] [Related]
4. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.
Borodic GE; Cozzolino D; Ferrante R; Wiegner AW; Young RR
Ophthalmic Plast Reconstr Surg; 1991; 7(1):54-60. PubMed ID: 1708272
[TBL] [Abstract][Full Text] [Related]
5. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
8. Treatment of blepharospasm with botulinum toxin.
Tsoy EA; Buckley EG; Dutton JJ
Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122
[TBL] [Abstract][Full Text] [Related]
9. Surgical technique for patients with the apractic type of essential blepharospasm: case report.
Smet H; De Wilde F; Tassignon MJ
Bull Soc Belge Ophtalmol; 1994; 254():85-8. PubMed ID: 7493130
[TBL] [Abstract][Full Text] [Related]
10. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
Lolekha P; Choolam A; Kulkantrakorn K
Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of blepharospasm with botulinum toxin A].
Költringer P; Haselwander H; Reisecker F
Wien Klin Wochenschr; 1990 Jul; 102(14):403-7. PubMed ID: 2382447
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated botulinum toxin injections on orbicularis oculi muscle.
Borodic GE; Ferrante R
J Clin Neuroophthalmol; 1992 Jun; 12(2):121-7. PubMed ID: 1385821
[TBL] [Abstract][Full Text] [Related]
13. Motor persistence of orbicularis oculi muscle in eyelid-opening disorders.
Aramideh M; Ongerboer de Visser BW; Koelman JH; Speelman JD
Neurology; 1995 May; 45(5):897-902. PubMed ID: 7746403
[TBL] [Abstract][Full Text] [Related]
14. Botulinum A toxin injection as a treatment for blepharospasm.
Scott AB; Kennedy RA; Stubbs HA
Arch Ophthalmol; 1985 Mar; 103(3):347-50. PubMed ID: 3977705
[TBL] [Abstract][Full Text] [Related]
15. Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm.
Burns CL; Gammon JA; Gemmill MC
Ophthalmology; 1986 Dec; 93(12):1621-7. PubMed ID: 3808621
[TBL] [Abstract][Full Text] [Related]
16. Serial SFEMG studies of orbicularis oculi muscle after the first administration of botulinum toxin.
Bogucki A
Eur J Neurol; 1999 Jul; 6(4):461-7. PubMed ID: 10362900
[TBL] [Abstract][Full Text] [Related]
17. The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm.
Esposito M; Fasano A; Crisci C; Dubbioso R; Iodice R; Santoro L
Neurol Sci; 2014 Mar; 35(3):397-400. PubMed ID: 23949734
[TBL] [Abstract][Full Text] [Related]
18. [Botulinum toxin type A (BOTOX) for treatment of blepharospasm: an open label, dose-response study].
Iwashige H; Nemoto Y; Takahashi H; Maruo T
Nippon Ganka Gakkai Zasshi; 1995 Jun; 99(6):663-8. PubMed ID: 7611002
[TBL] [Abstract][Full Text] [Related]
19. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in the management of blepharospasm.
Dutton JJ; Buckley EG
Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
